These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2101410)

  • 1. Skin involvement in Hodgkin's disease: a case report.
    Kim YC; Kawarazaki S; Inamoto Y; Takasu K
    Jpn J Med; 1990; 29(6):603-6. PubMed ID: 2101410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
    Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
    Kumagai K; Takagi T; Sakai C; Wakatsuki S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined modality (ABVD plus radiotherapy) versus radiotherapy in the management of early stage (IIA) Hodgkin's disease with mediastinal involvement.
    Anselmo AP; Bove M; Cartoni C; Damico C; Maurizi Enrici R; Falchetto Osti M; Biagini C
    Haematologica; 1992; 77(2):177-9. PubMed ID: 1383107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
    De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
    Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
    Schoeffler A; Levy E; Weinborn M; Cuny JF; Schmutz JL; Barbaud A; Cribier B; Bursztejn AC
    Ann Dermatol Venereol; 2014 Feb; 141(2):134-40. PubMed ID: 24507208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
    Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U
    Med Klin (Munich); 1992 Nov; 87(11):555-62. PubMed ID: 1281905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
    Preti A; Hagemeister FB; McLaughlin P; Swan F; Rodriguez A; Besa P; Cox JD; Allen PK; Cabanillas F
    Ann Oncol; 1994; 5 Suppl 2():97-100. PubMed ID: 7515653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinal involvement by Hodgkin's disease and the implications for management for those patients with local or loco-regional disease.
    Sutcliffe SB; Gospodarowicz M; Bush RS
    Hematol Oncol; 1984; 2(1):74-6. PubMed ID: 6735351
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin's disease.
    Villani F; Fede Catania A; Laffranchi A; Maffioli L; Viviani S; Bonfante V
    Cancer Invest; 2003 Apr; 21(2):185-92. PubMed ID: 12743983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
    J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
    Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
    García-Sanz R; González-López TJ; Vázquez L; Hermida G; Graciani IF; San Miguel JF
    Eur J Haematol; 2010 Mar; 84(3):266-70. PubMed ID: 19912314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
    Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG).
    Eich HT; Gossmann A; Engert A; Kriz J; Bredenfeld H; Hansemann K; Skripnitchenko R; Brillant C; Pfistner B; Staar S; Diehl V; Müller RP;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1187-92. PubMed ID: 17703895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection.
    Shaw MT; Jacobs SR
    Cancer; 1989 Dec; 64(12):2585-7. PubMed ID: 2819668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late recurrences in Hodgkin's disease: description of a case after 14 yr of continuous remission].
    Vila S; Zerga M; Villegas A; Somoza N
    Sangre (Barc); 1991 Apr; 36(2):163-5. PubMed ID: 1866655
    [No Abstract]   [Full Text] [Related]  

  • 20. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
    Zinzani PL; Barbieri E; Visani G; Gherlinzoni F; Perini F; Neri S; Bendandi M; Ammendolia I; Salvucci M; Babini L
    Haematologica; 1994; 79(6):508-12. PubMed ID: 7534744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.